Analyst Ratings For Antares Pharma (NASDAQ:ATRS)
Today, Piper Jaffray Companies reiterated its Buy rating on Antares Pharma (NASDAQ:ATRS) with a price target of $4.00.
There are 3 buy ratings, 1 strong buy rating on the stock.
The current consensus rating on Antares Pharma (NASDAQ:ATRS) is Buy (Score: 3.25) with a consensus target price of $4.58 per share, a potential 44.32% upside.
Some recent analyst ratings include
- 7/26/2017-Piper Jaffray Companies Reiterated Rating of Buy.
- 6/23/2017-Chardan Capital initiated coverage with a Buy rating.
- 6/23/2017-HC Wainwright Reiterated Rating of Buy .
- 4/20/2017-Raymond James Financial, Inc. initiated coverage with a Strong-Buy rating.
- 5/10/2016-Jefferies Group LLC Reiterated Rating of Buy.
- 9/25/2015-Oppenheimer Holdings, Inc. Reiterated Rating of Buy.
Recent Insider Trading Activity For Antares Pharma (NASDAQ:ATRS)
Antares Pharma (NASDAQ:ATRS) has insider ownership of 11.60% and institutional ownership of 32.07%.
- On 6/9/2017 Fred M Powell, Insider, bought 130,000 with an average share price of $2.79 per share and the total transaction amounting to $362,700.00. View SEC Filing
- On 4/5/2017 Robert F Apple, CEO, sold 40,000 with an average share price of $3.00 per share and the total transaction amounting to $120,000.00. View SEC Filing
- On 4/4/2017 Leonard S Jacob, Director, sold 41,762 with an average share price of $2.89 per share and the total transaction amounting to $120,692.18. View SEC Filing
- On 4/4/2017 Robert F Apple, CEO, sold 37,000 with an average share price of $3.00 per share and the total transaction amounting to $111,000.00. View SEC Filing
- On 4/3/2017 Leonard S Jacob, Director, sold 20,000 with an average share price of $2.88 per share and the total transaction amounting to $57,600.00. View SEC Filing
- On 3/31/2017 Thomas J Garrity, Director, sold 30,000 with an average share price of $2.91 per share and the total transaction amounting to $87,300.00. View SEC Filing
- On 12/9/2016 Fred M Powell, Insider, bought 100,000 with an average share price of $2.03 per share and the total transaction amounting to $203,000.00. View SEC Filing
Recent Trading Activity for Antares Pharma (NASDAQ:ATRS)
Shares of Antares Pharma closed the previous trading session at 3.17 down -0.01 -0.31% with 769,097 shares trading hands.